We deliver GMP-aligned customized facility design solutions dedicated to recombinant protein manufacturing, covering microbial expression, mammalian cell culture, protein purification and sterile formulation for therapeutic proteins, enzymes and biocatalysts. All layout planning and system configuration strictly comply with FDA cGMP, EU GMP and ISO 14644 cleanroom standards, fully adapting to the unique process characteristics of protein biosynthesis, impurity removal and stability control. Adopting quality-by-design and contamination-prevention principles, we build audit-ready production facilities that support consistent batch quality, high protein yield and full regulatory compliance for clinical trial and commercial-scale protein manufacturing.
Our recombinant protein-specific facility design features process-driven functional zoning and graded environmental control to eliminate cross-contamination and stabilize bioproduction conditions. We implement independent segregated areas for strain revival, seed culture, large-scale fermentation or cell culture, supernatant clarification, multi-stage chromatographic purification, ultrafiltration concentration and final formulation. Strict unidirectional personnel, material and waste flow routes prevent cross-over pollution between upstream bioprocessing and downstream purification zones. Customized ISO 5 to ISO 8 cleanroom grading, stable pressure gradient systems and temperature-humidity locking structures effectively protect protein activity, reduce microbial contamination and minimize protein denaturation or aggregation risks throughout production.
Covering full-lifecycle turnkey engineering design services, our scope includes protein process-oriented master planning, GMP-compliant workshop layout optimization, cleanroom structural design, specialized HVAC and utility system deployment, sanitary process pipeline layout, dedicated equipment foundation and skid matching, on-site commissioning and complete GMP validation document support. All production contact surfaces adopt dead-zone-free polished design with full CIP cleaning and SIP sterilization compatibility, adapting to frequent batch switching and long-term continuous protein production. Full-process environmental monitoring and data traceability systems meet global regulatory audit and batch release requirements.
Empowered by rich recombinant protein biomanufacturing engineering experience, our facility design solves core industry pain points including low process stability, high impurity rates and easy cross-contamination. Process-tailored spatial optimization improves production efficiency and protein finished product qualification rates while reducing buffer consumption and operational costs. Modular scalable layout supports flexible switching between pilot process verification and large-scale commercial production, accommodating iterative protein product upgrades and capacity expansion. We help biopharmaceutical enterprises build stable, compliant and future-proof recombinant protein manufacturing facilities to accelerate product registration, clinical application and global commercialization.
